-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 26, INOVIO announced that it is planning to conduct a phase 3 trial for its new crown vaccine candidate INO-4800, which is mainly carried out outside the United States.
Public information shows that INO-4800 is a candidate DNA vaccine against COVID-19, and Advaccine has the exclusive rights to the candidate vaccine in Greater China.
DNA vaccine, also known as nucleic acid vaccine or genetic vaccine, refers to the introduction of a DNA sequence encoding a certain protein antigen into a host through a vector to induce the body to produce an immune response.
INO-4800 is a candidate DNA vaccine developed by INOVIO, which can be used against the coronavirus SARS-CoV-2 that causes new coronary pneumonia.
In January 2020, Ai Di Weixin and INOVIO reached a cooperation to develop INO-4800 in China.
It is reported that INO-4800 has many advantages, including: it can be stable for at least one year at room temperature, and it can be stable for at least one month at 37°C.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.